At a glance
ClinicalIndex Comparison RecordN/ACompleted· 129 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Observational, Cross-sectional, Multicenter Descriptive Study of the Patient Clinical Profile That Begins With Disseminated Her 2 + Breast Cancer or Develops a Metastasis After or During the Adjuvant Therapy (PRIMHER)
Asociación Cacereña para la Investigación y el Desarrollo en Oncología Médica·observational·Posted Jul 20, 2012·Updated Jan 8, 2014
In Brief
An observational study for Disseminated HER2+ Breast Cancer. Completed, enrolled 129 participants across 39 sites.
Detailed Summary
This is an observational, cross-sectional study that the main objective is to describe the patient clinical profile that begins with disseminated Her 2+ Breast Cancer or develops a metastasis after or during the adjuvant treatment.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDisseminated HER2+ Breast Cancer
CountriesSpain
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2011
First PostedJul 2012
Primary CompletionMar 2013
TodayJul 2026
First PostedJul 20, 2012
Enrollment StartJul 1, 2011
Primary CompletionMar 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 14.0 years ago